Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Prenetics Global Limited (PRE)

NGM · Diagnostics & Research

$18.26-0.67 (-3.54%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$310.4M
P/E (TTM)
EPS
$-3.50
Div Yield
52W Range
$7.17–$23.63
Beta
0.25

Company overview

Next earnings: 2026-08-10(13d)

Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Peers in Diagnostics & Research

All in industry →

Recent press releases

Prenetics Global Limited has not issued a press release in this window.

SEC filings

All filings →

Prenetics Global Limited has not filed an SEC document in this window.

Prenetics Global Limited has no reported insider trades in the last 90 days.

Institutional holders

All holders →

No 13F holdings have been reported for Prenetics Global Limited in this window.

People at Prenetics Global Limited

All people →

Quarterly financials

Full financials →

No quarterly financials have been ingested for Prenetics Global Limited.